About Maha Radhakrishnan
Maha Radhakrishnan is a director at Claris Biotherapeutics.
Experience
This experience comes from Maha Radhakrishnan's profile and from SEC filings. For roles taken from filings, the years are when the filings name Maha Radhakrishnan in the role, so the role may have started earlier or lasted longer.
Claris Biotherapeutics, Inc. Current
Director Board of Directors
2026 – Present · Half Moon Bay, CA
Develops eye treatments for people with sight-threatening corneal diseases.
CT
Candel Therapeutics Current
Board Member
2025 – Present
ET
Entrada Therapeutics Current
Board Member
2025 – Present
SI
Sofinnova Investments Current
Executive Partner
2024 – Present
CT
City Therapeutics
Board Observer
2026
AN
Alto Neuroscience
Board Member
2024 – 2025
BI
Biogen
Chief Medical Officer
2013 – 2024
SA
Sanofi
Senior Vice President, Global Medical Head, Primary Care Business Unit, Sanofi
2018 – 2020
BC
Bioverativ, a Sanofi company
Senior Vice President, Head of Medical, Bioverativ
2016 – 2018
BS
Bristol-Myers Squibb
Executive Director, Immunoscience & Neuroscience, Global Medical Head Quarters
2009 – 2013
Key Colleagues at Startups
The people Maha Radhakrishnan works with at each company, as listed on that company's latest Form D.
Claris Biotherapeutics, Inc. · Form D/A, Aug 12, 2026
Brian Baum
Chief Commercial Officer
MF
Meredith Fisher
Director
RD
Reza Dana
Director
Stephen Brady
President and Chief Executive Officer, director
Henry Rath
Chief Business Officer
KH
Kenneth Harrison
Director
MH
Matt Hobson
Director
MD
Michael Dybbs
Director
Susan Orr
Chief Medical Officer
Clarke Atwell
Co-Founder and Chief Operating Officer
MG
Marc de Garidel
Director